Point-of-care testing system for rapid diagnostic analysis. Integrates microfluidics technology to deliver quick results for clinical decision-making in laboratory and field settings.
Manufactured by
MedFluid Co., Ltd.
Zhubei City, Hsinchu County, Taiwan
https://medfluid.com.tw/ NAST, the world s first in-clinic antibiotic susceptibility test analyzer. Founded in 2019 by experts in microfluidics, p owered by patented microfluidics, NAST delivers accurate results within 6 hours. Validated over 4 years in veterinary markets, it enables rapid, evidence-based treatment decisions for animal care. The team develops microfluidic platforms for rapid detection tools of disease diagnosis and precision treatments to improve the health and well-being of patients.
© 2026 Suplivia · Home · Browse Products